Home>
US Stocks>
Galectin Therapeutics

Galectin Therapeutics share price today

(GALT)

Galectin Therapeutics share price is $1.04 & ₹88.38 as on 21 Dec 2024, 2.30 'hrs' IST

$1.04

▲

-0.96

(-48%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Galectin Therapeutics share price in Dollar and Rupees. Guide to invest in Galectin Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Galectin Therapeutics. Get details on the Indian mutual funds that are investing in Galectin Therapeutics. Get Analyst recommendations and forecasts along with all the Galectin Therapeutics's financials.

Galectin Therapeutics share price movements

Today's Low: $0.76
Today's High: $1.45
$1.04
27.06%
Downside
Day's Volatility :47.5%
Upside
28.03%
52 Weeks Low: $0.73
52 Weeks High: $4.27
$1.04
30.19%
Downside
52 Weeks Volatility :82.99%
Upside
75.63%

Galectin Therapeutics Returns

Period	Galectin Therapeutics Inc	Index (Russel 2000)
3 Months	-61.76%	0.0%
6 Months	-51.17%	0.0%
1 Year	-35.8%	0.0%
3 Years	-16.13%	-19.7%

Galectin Therapeutics Key Statistics

in dollars & INR

Previous Close	$2.0
Open	$1.18
Today's High	$1.445
Today's Low	$0.7586
Market Capitalization	$65.3M
Today's Volume	$9.2M
52 Week High	$4.2684
52 Week Low	$0.726041
Revenue TTM	$0.0
Earnings Per Share (EPS)	$-0.73
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-3727.95%

How to invest in Galectin Therapeutics from India?

It is very easy for Indian residents to invest directly in Galectin Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Galectin Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Galectin Therapeutics or GALT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Galectin Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Galectin Therapeutics shares which would translate to 0.817 fractional shares of Galectin Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Galectin Therapeutics, in just a few clicks!

Returns in Galectin Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Galectin Therapeutics investment value today

Current value as on today

₹1,37,999

Returns

₹37,999

(+38%)

Returns from Galectin Therapeutics Stock

₹35,802 (false-35.8%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Galectin Therapeutics

110%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Galectin Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 110% more investors are searching Galectin Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Galectin Therapeutics

Vanguard Group Inc
3.40%
BlackRock Inc
2.49%
Advisor Group Holdings, Inc.
1.88%
Geode Capital Management, LLC
1.37%
Commonwealth Equity Services Inc
0.77%
Sontag Advisory LLC
0.63%

Analyst Recommendation on Galectin Therapeutics

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Galectin Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Galectin Therapeutics

What analysts predicted

Upside of 957.69%

Current:

$1.04

Target:

$11.00

Insights on Galectin Therapeutics

Price Movement
In the last 7 days, GALT stock has moved down by -50.7%
GALT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 77.1%

Galectin Therapeutics Technicals Summary

Sell

Neutral

Buy

Galectin Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Galectin Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Galectin Therapeutics Inc	-62.59%	-51.17%	-35.8%	-16.13%	-16.13%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.38%	12.23%	86.41%
Biontech Se	4.48%	30.56%	7.97%	-55.71%	237.85%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.37%	26.29%	108.55%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-2.55%	77.79%	80.12%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Galectin Therapeutics Inc	NA	NA	0.0	0.0	-37.28	-1.04	NA	-1.01
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Galectin Therapeutics Inc	Buy	$65.3M	-16.13%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	86.41%	17.51	33.61%
Biontech Se	Buy	$26.7B	237.85%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	108.55%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.12%	32.84	-4.51%

About Galectin Therapeutics

galectin therapeutics (nasdaq: galt) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. drug candidates based on the company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function. we use naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. using these unique carbohydrate-based candidate compounds that bind and inhibit galectin proteins, we are pursuing therapies for indications where galectins have a demonstrated role in the pathogenesis of a particular disease. we focus on diseases with serious, life threatening consequences to patients, and those where current treatment options are limited. our strategy is to establish clinical development approaches that add value to the company in the shortest time possible, and to seek partners as the program advances and requires much

Organization	Galectin Therapeutics
Employees	14
CEO	Mr. Jack W. Callicutt CPA
Industry	Health Technology

Management People of Galectin Therapeutics

Name	Title
Mr. Jack W. Callicutt CPA	CFO, Treasurer & Corporate Secretary
Mr. Jeff Katstra	Head of CMC & Pharmaceutical Development
Mr. Khurram Jamil M.D.	Chief Medical Officer
Ms. Beth Knowles	Executive Assistant & Officer Manager

Important FAQs about investing in Galectin Therapeutics from India :

What is Galectin Therapeutics share price today?

Galectin Therapeutics share price today stands at $1.04, Open: $1.18 ; Previous Close: $2.00 ; High: $1.45 ; Low: $0.76 ; 52 Week High: $4.27 ; 52 Week Low: $0.73. The stock opens at $1.18, after a previous close of $2.00. The stock reached a daily high of $1.45 and a low of $0.76, with a 52-week high of $4.27 and a 52-week low of $0.73.

Can Indians buy Galectin Therapeutics shares?

Yes, Indians can invest in the Galectin Therapeutics (GALT) from India.

With INDmoney, you can buy Galectin Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Galectin Therapeutics at zero transaction cost.

How can I buy Galectin Therapeutics shares from India?

It is very easy to buy Galectin Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Galectin Therapeutics be purchased?

Yes, you can buy fractional shares of Galectin Therapeutics with INDmoney app.

What are the documents required to start investing in Galectin Therapeutics stocks?

To start investing in Galectin Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.